Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David R. Byrd

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

Clinical Cancer Research

Cancer Research

Oncology

2018

English

A New American Joint Committee on Cancer Staging System for Cutaneous Squamous Cell Carcinoma: Creation and Rationale for Inclusion of Tumor (T) Characteristics

Journal of the American Academy of Dermatology

Dermatology

2011

English

Related publications

Pilot Study of Intratumoral G100, Toll-Like Receptor-4 (TLR4) Agonist, Therapy in Patients With Merkel Cell Carcinoma (MCC).

Journal of Clinical Oncology

English

Intratumoral Treatment of One Tumor Lesion With LTX-315 Induces Complete Tumor Regression and Long-Term Specific Protective Immune Responses in a Metastatic Rodent Tumor Model

Journal for ImmunoTherapy of Cancer

English

PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice With Tumoral T Lymphoblasts

Journal of Oncology

Oncology

2019

English

Caveolin-2 Deficiency Induces a Rapid Anti-Tumor Immune Response Prior to Regression of Implanted Murine Lung Carcinoma Tumors

Scientific Reports

Multidisciplinary

2019

English

Human Tumor-Derived Genomic DNA Transduced Into a Recipient Cell Induces Tumor-Specific Immune Responses Ex Vivo

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2002

English

Anti-Tumor Immune Responses Induced by Radiotherapy: A Review

Fukushima Journal of Medical Sciences

Medicine

2015

English

Autologous Tumor Cell Vaccination Combined With Systemic CpG-B and IFN-α Promotes Immune Activation and Induces Clinical Responses in Patients With Metastatic Renal Cell Carcinoma: A Phase II Trial

Cancer Immunology, Immunotherapy

English

Correlation Between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated With a MAGE Antigen

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2004

English

Intratumoral Injection of Ad-Isf35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by David R. Byrd

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

A New American Joint Committee on Cancer Staging System for Cutaneous Squamous Cell Carcinoma: Creation and Rationale for Inclusion of Tumor (T) Characteristics

Related publications

Pilot Study of Intratumoral G100, Toll-Like Receptor-4 (TLR4) Agonist, Therapy in Patients With Merkel Cell Carcinoma (MCC).

Intratumoral Treatment of One Tumor Lesion With LTX-315 Induces Complete Tumor Regression and Long-Term Specific Protective Immune Responses in a Metastatic Rodent Tumor Model

PKHB1 Tumor Cell Lysate Induces Antitumor Immune System Stimulation and Tumor Regression in Syngeneic Mice With Tumoral T Lymphoblasts

Caveolin-2 Deficiency Induces a Rapid Anti-Tumor Immune Response Prior to Regression of Implanted Murine Lung Carcinoma Tumors

Human Tumor-Derived Genomic DNA Transduced Into a Recipient Cell Induces Tumor-Specific Immune Responses Ex Vivo

Anti-Tumor Immune Responses Induced by Radiotherapy: A Review

Autologous Tumor Cell Vaccination Combined With Systemic CpG-B and IFN-α Promotes Immune Activation and Induces Clinical Responses in Patients With Metastatic Renal Cell Carcinoma: A Phase II Trial

Correlation Between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated With a MAGE Antigen

Intratumoral Injection of Ad-Isf35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression